Abstract
This chapter sets out crucial ethical and legal issues raised both by existing targeted genetic testing, and, more importantly, by the rising tide of broader genomic tests, such as whole-genome sequencing (WGS). Clinical genetic testing has been available for over 40 years, but not all the concerns have been resolved. The chapter discusses those concerns in traditional targeted testing in five categories: the decision whether to test, the tests’ accuracy, conveying the results to patients, direct-to-consumer testing, and a variety of other concerns. It then discusses intermediate forms of testing, tests such as multiplex tandem mass spectrometry and SNP arrays, that do not provide information about only a handful of genetic variants, but also do not provide powerful information about many disease-linked variants. It ends by discussing how WGS and other “broad” tests will greatly exacerbate the ethical and legal problems of existing testing methods, particularly with respect to accuracy, conveying results, and confidentiality.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Am College Med Genet (2008) ACMG statement on direct-to-consumer genetic testing. https://www.acmg.net/docs/ACMG_Statement_on_DTC_4.07.08.pdf
Am College Med Genet (2012) Points to consider in the clinical application of genomic sequencing. http://www.acmg.net/StaticContent/PPG/Clinical_Application_of_Genomic_Sequencing.pdf. Accessed 5 Jul 2013
Am College Med Genet (2013) Incidental findings in clinical genomics: a clarification.www.acmg.net/docs/Incidental_Findings_in_Clinical_Genomics_A_Clarification.pdf. Accessed 5 Jul 2013.
Ashley EA et al. Clinical assessment incorporating a personal genome. Lancet. 2010;375:1525–35.
Association for Molecular Pathology v. Myriad Genetics, Inc. 2013. _U.S. __, 133 S.Ct. 1958.
Biesecker LG. Opportunities and challenges for the integration of massively parallel genomic sequencing into clinical practice: lessons from the ClinSeq project. Genet Med. 2012;14:393–8.
Clayton EW et al. Managing incidental genomic findings: legal obligations of clinicians. Genet Med. 2013;15:624–9.
DNA DTC. Products. 2013. http://www.dnadtc.com/. Accessed 2 Sept 2013.
Genome Web. Lab group submits citizen petition against FDA regulation of lab developed tests. 2013. http://www.genomeweb.com/print/1237821?hq_e=el&hq_m=1588054&hq_l=1&hq_v=162223e076. Accessed 24 Aug 2013.
Genome Web. Members of Congress Urge Obama Administration to Release FDA Draft Guidance on LDT Regulation. 2013. http://www.genomeweb.com/clinical-genomics/members-congress-urge-obama-administration-release-fda-draft-guidance-ldt-regula. Accessed 24 Aug 2013.
Global Alliance. Creating a global alliance to enable responsible sharing of genomic and clinical data. 2013. http://www.broadinstitute.org/news/globalalliance. Accessed 2 Sept 2013.
Government Accountability Office. Direct-to-consumer genetic tests: misleading test results are further complicated by deceptive marketing and other questionable practices. Washington, DC: GAO; 2010.
Greely HT. “Genotype Discrimination”: the complex case for some legislative protection. Univ PA Law Rev. 2001;149:1483–505.
Greely HT. Human genomics research: new challenges for research ethics. Perspect Biol Med. 2001;44(2):221–9.
Greely HT. The uneasy ethical and legal underpinnings of large-scale genomic biobanks. Annu Rev Genomics Hum Genet. 2007;8:343–64.
Greely HT. Testing infant destinies. Nature. 2012;492:192.
Green RC et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15:565–74.
Green RC et al. Clinical genome sequencing. In: Ginsburg G, Willard H, editors. Genomic and personalized medicine. 2nd ed. San Diego: Elsevier; 2013. p.102–22.
Hayden EC. Geneticists push for global data sharing. Nature. 2013;498:16–7.
Lam HY et al. Performance comparison of whole genome sequencing platforms. Nat Biotech. 2012;30:78–82.
Manolio TA et al. Implementing genomic medicine in the clinic: the future is here. Genet Med. 2013;15(4):258–67.
Mayer AN et al. A timely arrival for genomic medicine. Genet Med. 2011;13:195–6.
McGuire AL et al. Ethics and genomic incidental findings. Science. 2013;340:1047–8.
Ng PC et al. An agenda for personalized medicine. Nature. 2009;461:724–6.
Ormond KE et al. Challenges in the clinical application of whole-genome sequencing. Lancet. 2010;375:1749–51.
Ross LF et al. Technical report: ethical and policy issues in genetic testing and screening of children. Genet Med. 2013;15:234–45.
Schrijver I et al. Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the association for molecular pathology. J Mol Diagn. 2012;15:525–40.
Timmermans S, Buchbinder M. Saving babies?: the consequences of newborn screening. Chicago: University of Chicago Press; 2012.
van El CG et al. Whole-genome sequencing in health care: recommendations of the European Society of human genetics. Euro J Hum Gen. 2013;21:580–4.
Wolf SM et al. Patient autonomy and incidental findings in clinical genomics. Science. 2013;340:1049–50.
Zettler PJ et al. 23andMe, the Food and Drug Administration, and the future of genetic testing. JAMA. 2014;174(4):493–4. doi:10.1001/jamainternmed.2013.14706.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Greely, H.T. (2015). Ethical Issues in Clinical Genetics and Genomics. In: Netto, G., Schrijver, I. (eds) Genomic Applications in Pathology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0727-4_11
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0727-4_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-0726-7
Online ISBN: 978-1-4939-0727-4
eBook Packages: MedicineMedicine (R0)